FLVCR2 and cancer: We compared the expression levels and activity of CCT/TRiC in 18 cancer cell lines from different organs and a normal cell line (MRC5-SV2), a human non-cancer liver homogenate (HNCL) and rabbit reticulocyte lysate (RRL), where CCT/TRiC is known to be expressed and highly active.